CUSIP 92941V308COMVYNEQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
42 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Shay Capital LLC | 1.62M | $942.3K | +1.13M | Added |
| 2 | Anson Funds Management LP | 1.27M | $739.3K | +1.27M | New |
| 3 | Nantahala Capital Management, LLC | 1.00M | $580.1K | +1.00M | New |
| 4 | T3 Companies, LLC | 945.0K | $548.2K |
| New Position |
| 5 | Kvp Capital Advisors, LP | 500.6K | $290.4K | +500.6K | New Position |
| 6 | Vanguard Group Inc | 314.5K | $182.4K | +124.2K | Added |
| 7 | Ikarian Capital, LLC | 264.9K | $153.7K | −25.1K | Reduced |
| 8 | Adar1 Capital Management, LLC | 253.8K | $147.2K | +253.8K | New |
| 9 | Geode Capital Management, LLC | 225.2K | $130.6K | +88.0K | Added |
| 10 | Two Sigma Investments, LP | 220.0K | $127.6K | −788 | Reduced |
See every fund holding Vyne Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders